GlassScriptPhysician profile
Mohamed A S Ali
NPI 1285607135
$3,274.29
in general payments reported to CMS, 2019-2025
31 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $345 · 2021: $234 · 2022: $668 · 2023: $563 · 2024: $656 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $594.92 | 2019-2021 | |
| Lilly USA, LLC | $270.12 | 2019-2024 | Mounjaro, Zepbound |
| Amgen INC. | $215.12 | 2022-2025 | Repatha, Otezla, Evenity |
| Biosense Webster, INC. | $196.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $179.11 | 2019-2025 | |
| Astellas Pharma US INC | $174.40 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.32 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Medtronic, INC. | $137.78 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Novo Nordisk INC | $135.44 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $121.50 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $117.95 | 2019-2024 | Lokelma, Breztri |
| Integra Lifesciences Corporation | $112.44 | 2019 | |
| Abbvie INC. | $105.72 | 2022-2025 | |
| Glaxosmithkline, LLC. | $91.66 | 2019-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $85.23 | 2020-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $66.25 | 2024 | Ingrezza |
| Ironwood Pharmaceuticals, INC | $60.10 | 2022-2024 | Linzess |
| Janssen Pharmaceuticals, INC | $57.50 | 2022 | |
| Merck Sharp & Dohme LLC | $53.97 | 2022-2024 | Gardasil 9, Gardasil, Capvaxive |
| Dexcom, INC. | $51.41 | 2022-2023 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $45.53 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $38.97 | 2024 | Freestyle Libre 3 |
| Boston Scientific Corporation | $37.79 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $34.04 | 2024-2025 | Eliquis, Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.33 | 2023-2024 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.61 | 2022 | |
| Scilex Pharmaceuticals INC. | $17.04 | 2019 | |
| Acadia Pharmaceuticals INC | $15.87 | 2023 | Nuplazid |
| Aimmune Therapeutics, INC. | $15.50 | 2025 | Zenpep |
| Sanofi Pasteur INC. | $13.67 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.